Skip to main content
SpringerLink
Log in

Systematic testing in cholera surveillance enhances vaccine impact and cost-effectiveness

  • Research Briefing
  • Published:

From Nature Medicine

View current issue Submit your manuscript

Most suspected cholera cases are not tested for Vibrio cholerae. Integrating systematic testing into cholera surveillance systems, even with imperfect rapid diagnostic tests, could yield large gains in efficiency and cost savings in the geographic targeting of mass oral cholera vaccination campaigns.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1: Public health impact and cost-efficiency of enhanced systematic testing.

References

  1. Wiens, K. E. et al. Estimating the proportion of clinically suspected cholera cases that are true Vibrio cholerae infections: a systematic review and meta-analysis. PLoS Med. 20, e1004286 (2023). This systematic review and meta-analysis estimates the true underlying proportion of suspected cholera cases that are true V. cholerae infections across test types, clinical case definitions and transmission settings.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Bi, Q. et al. Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis. Lancet Inf. Dis. 17, 1080–1088 (2017). This systematic review and meta-analysis estimates the duration of OCV efficacy and effectiveness over time and in different age groups.

    Article  CAS  Google Scholar 

  3. Lessler, J. et al. Mapping the burden of cholera in sub-Saharan Africa and implications for control: an analysis of data across geographical scales. Lancet 391, 1908–1915 (2018). This article maps the burden of cholera in Africa from 2010 to 2016 and projects the potential impact of targeting OCV campaigns according to the highest burden areas in this region.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Pezzoli, L. Global oral cholera vaccine use, 2013–2018. Vaccine 38, A132–A140 (2020). This article presents data on OCV requests and shipments from the global OCV stockpile from 2013 to 2018.

    Article  PubMed  Google Scholar 

  5. Lee, E. C. et al. The projected impact of geographic targeting of oral cholera vaccination in sub-Saharan Africa: a modeling study. PLOS Med. 16, e1003003 (2019). This article highlights the necessity of geographic targeting of mass OCV campaigns to increase efficient use of the vaccine.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Xu, H. et al. Enhanced cholera surveillance to improve vaccination campaign efficiency. Nat. Med. https://doi.org/10.1038/s41591-024-02852-8 (2024).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Systematic testing in cholera surveillance enhances vaccine impact and cost-effectiveness. Nat Med 30, 950–951 (2024). https://doi.org/10.1038/s41591-024-02907-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-024-02907-w

  • Springer Nature America, Inc.

Search

Navigation